2,6-Dihydroxypurine structure
|
Common Name | 2,6-Dihydroxypurine | ||
---|---|---|---|---|
CAS Number | 69-89-6 | Molecular Weight | 152.111 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 834.9ºC at 760 mmHg | |
Molecular Formula | C5H4N4O2 | Melting Point | 300 °C | |
MSDS | Chinese USA | Flash Point | 458.7ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of 2,6-DihydroxypurineXanthine is a purine base found in most human body tissues and fluids and in other organisms. |
Name | 7H-xanthine |
---|---|
Synonym | More Synonyms |
Description | Xanthine is a purine base found in most human body tissues and fluids and in other organisms. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
In Vitro | A number of stimulants are derived from Xanthine including caffeine and theobromine. Xanthine is a product on the pathway of purine degradation. Xanthine is subsequently converted to uric acid by the action of the Xanthine oxidase enzyme. |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 834.9ºC at 760 mmHg |
Melting Point | 300 °C |
Molecular Formula | C5H4N4O2 |
Molecular Weight | 152.111 |
Flash Point | 458.7ºC |
Exact Mass | 152.033432 |
PSA | 94.40000 |
LogP | -0.81 |
Index of Refraction | 1.636 |
Storage condition | Store at RT. |
Water Solubility | NH4OH: freely soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H317-H319 |
Precautionary Statements | P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36;R43 |
Safety Phrases | S36/37 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | ZD7700000 |
HS Code | 2933990090 |
Precursor 10 | |
---|---|
DownStream 10 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Fungal metabolite nigerloxin ameliorates diabetic nephropathy and gentamicin-induced renal oxidative stress in experimental rats.
Naunyn Schmiedebergs Arch. Pharmacol. 387(9) , 849-59, (2014) Elevated polyol pathway enzyme activities and oxidative stress play an important role in the development and progression of diabetic nephropathy. Here, we investigated the beneficial influence of nige... |
|
Antioxidant Capacities and Analysis of Phenolic Compounds in Three Endemic Nolana Species by HPLC-PDA-ESI-MS.
Molecules 20 , 11490-507, (2015) The antioxidant features, polyphenolic composition and chromatographic fingerprints of the aerial parts from three Chilean endemic plants from the Paposo Valley located on the cost of the Atacama Dese... |
|
Spironolactone and dimethylsulfoxide effect on glucose metabolism and oxidative stress markers in polycystic ovarian syndrome rat model.
Exp. Clin. Endocrinol. Diabetes 122(3) , 154-62, (2014) Because polycystic ovarian syndrome (PCOS) is a risk factor for type 2 diabetes, the affected women can present frequently prediabetic states such as impaired fasting glycaemia and/or impaired glucose... |
UREOUS ACID |
Xan |
xanthicoxide |
Dioxopurine |
9H-xanthine |
2,5-DIFLUOROTHIOBENZAMIDE |
usafcb-17 |
Xanthine |
9H-Purine-2,6(1H,3H)-dione |
Purine-2,6(1H,3H)-dione |
Xanthin |
ISOXANTHINE |
2,6-Dihydroxypurine |
MFCD00078453 |
3,7-dihydropurine-2,6-dione |
Xanthione |
EINECS 200-718-6 |
3,7-dihydro-1H-purine-2,6-dione |
1H-Purine-2,6-dione, 3,7-dihydro- |
3,7-dihydro-purine-2,6-dione |
2,6(1H,3H)-Purinedione |